Limited Period Offer:Be a PRO for 1 month @Rs49/-Multiple payment options available. Know More
you are here: HomeNewsBusiness

Strides Pharma Science Q4 PAT may dip 488.7% YoY to Rs. 72.3 cr: Sharekhan

Net Sales are expected to increase by 31 percent Y-o-Y (down 2.6 percent Q-o-Q) to Rs. 810.3 crore, according to Sharekhan.

April 12, 2021 / 09:02 PM IST
 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

Sharekhan has come out with its fourth quarter (January-March’ 21) earnings estimates for the Pharmaceuticals sector. The brokerage house expects Strides Pharma Science to report net profit at Rs. 72.3 crore down 488.7% year-on-year (up 51.6% quarter-on-quarter).


Net Sales are expected to increase by 31 percent Y-o-Y (down 2.6 percent Q-o-Q) to Rs. 810.3 crore, according to Sharekhan.


Disclaimer: The views and investment tips expressed by investment experts on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

Broker Research

stay updated

Get Daily News on your Browser
Sections